Slco6c1 inhibitors are a class of chemical compounds designed to specifically inhibit the function of solute carrier organic anion transporter family member 6C1 (Slco6c1). Slco6c1 is a member of the SLC family of transporters, which are integral membrane proteins involved in the transport of organic anions and various other molecules across cell membranes. These transporters play crucial roles in maintaining the balance of molecules such as hormones, metabolites, and xenobiotics within and between cells. Slco6c1, like other members of this family, is responsible for the facilitated movement of its specific substrates, and inhibitors that target Slco6c1 are designed to disrupt this process by binding to the transporter, thus blocking its normal function. By interfering with the transport activity of Slco6c1, these inhibitors modulate the flow of substrates that are critical for cellular processes, allowing researchers to study the transporter's specific role in cellular homeostasis.
In the development of Slco6c1 inhibitors, structural biology plays a key role. Researchers study the molecular structure of Slco6c1, often using techniques such as X-ray crystallography or molecular modeling, to identify potential binding sites where inhibitors can effectively interact with the transporter. The design of these inhibitors typically involves optimizing their ability to selectively bind to Slco6c1 without affecting other similar transporters in the SLC family, which requires a deep understanding of the protein's unique structural features. Biochemical assays are employed to evaluate the binding affinity, specificity, and inhibitory effects of these compounds. Through these studies, scientists are able to explore the broader biological functions of Slco6c1 and gain insights into the regulatory mechanisms of organic anion transporters. Understanding the action of Slco6c1 inhibitors contributes to a broader comprehension of solute carrier-mediated transport and its role in maintaining cellular and systemic balance.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin, an antibiotic, is known to broadly affect SLCO transporters by inducing their expression, which could indirectly modify SLCO6C1 activity. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporine A, an immunosuppressant, inhibits multiple SLCO transporters, potentially affecting SLCO6C1 function by altering substrate competition. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Gemfibrozil, a lipid-lowering drug, interacts with various SLCO transporters, possibly influencing SLCO6C1 activity through modulation of lipid metabolism. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Atorvastatin, a statin, is a substrate for several SLCO transporters, potentially affecting SLCO6C1 by altering transporter availability or specificity. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
Indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), is known to interact with SLCO transporters, which could extend to SLCO6C1, influencing its transport efficiency. | ||||||
Probenecid | 57-66-9 | sc-202773 sc-202773A sc-202773B sc-202773C | 1 g 5 g 25 g 100 g | $28.00 $39.00 $100.00 $277.00 | 28 | |
Probenecid can inhibit the function of several SLCO transporters, possibly affecting SLCO6C1 by modulating competition for anionic substrates. | ||||||
Silymarin group, mixture of isomers | 65666-07-1 | sc-301806 | 50 g | $325.00 | ||
Silymarin, a mixture of flavonolignans from milk thistle, is thought to affect SLCO transporter activity, potentially modulating SLCO6C1 indirectly. | ||||||
Itraconazole | 84625-61-6 | sc-205724 sc-205724A | 50 mg 100 mg | $78.00 $142.00 | 23 | |
Itraconazole, an antifungal agent, has been shown to inhibit several SLCO transporters, which might include SLCO6C1, affecting its function. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $57.00 $245.00 $831.00 $1331.00 | 4 | |
Erythromycin, an antibiotic, interacts with SLCO transporters, potentially modulating SLCO6C1 activity through competition or inhibition. | ||||||
Nelfinavir | 159989-64-7 | sc-507314 | 10 mg | $168.00 | ||
Nelfinavir, an antiretroviral drug, has been reported to inhibit SLCO transporter activity, which could affect SLCO6C1 indirectly. | ||||||